Strategies of Therapy With the Exoskeleton Robot ARMin (MultiVIT-ARMin)
Strategies of Therapy With the Exoskeleton Robot ARMinMulti VIT-ARMin
Sponsor: Rehaklinik Zihlschlacht AG
This NA trial investigates Stroke and is currently completed. Rehaklinik Zihlschlacht AG leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Phase: PHASE1_PHASE2 → NA
▶ Show 4 earlier versions
-
Nov 2019 — Aug 2020 [monthly]
Completed PHASE1_PHASE2
-
Jan 2019 — Nov 2019 [monthly]
Completed PHASE1_PHASE2
Status: Not Yet Recruiting → Completed
-
Jun 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
May 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Rehaklinik Zihlschlacht AG
- Swiss Federal Institute of Technology
For direct contact, visit the study record on ClinicalTrials.gov .